Report Categories
View AllRecent Articles
View All
NTLA Intellia Therapeutics shares rise 832 percent after narrower Q4 2025 loss beats analyst expectations
NXG NXG signals focus on expanding highyield infrastructure assets in postquarter earnings briefing
TATT TAT Technologies posts narrow Q4 2025 EPS miss shares drop 7 on weak investor sentiment
FSBC Five Star notches 84 percent first quarter 2026 earnings per share upside stock rises 115 percent today